共 50 条
- [6] The role of CYP3A5 polymorphism and dose adjustments following conversion of twice-daily to once-daily tacrolimus in renal transplant recipients [J]. TRANSPLANTATION RESEARCH, 2016, 5
- [7] Impact of CYP3A5 genotype and cystic fibrosis on extended-release tacrolimus (LCPT) exposure in lung transplant recipients [J]. PHARMACOGENETICS AND GENOMICS, 2023, 33 (08): : 199 - 200
- [10] A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicity [J]. TRANSPLANTATION RESEARCH, 2014, 3